Tag: Canada
-
Smartphone Test Results Speed Hospital Patient Release
Results of lab tests sent to doctors’ smartphones can speed the release of emergency room patients by nearly a half-hour, according to a newly published study.
-
Trial to Examine Immune System Workings
Unlike conventional clinical studies testing a particular treatment, this trial aims to explore in more detail the body’s interactions with a class of drugs, in this case vaccines.
-
Messenger RNA Engineered to Produce Antibodies
Academic and industry researchers demonstrated production of therapeutic antibodies inside cells of lab mice, offering a simpler and lower-cost alternative to monoclonal antibodies.
-
Public Access to Drugs Meets Health Needs, Cuts Costs
A study shows adding universal access to essential drugs as part of Canada’s health care system would meet much of that country’s pharmaceutical needs and save billions of dollars.
-
Nuclear Cancer Therapy Company Launches, Raises $25M
A new company developing cancer therapies combining nuclear radiation and synthetic antibodies is starting up in Hamilton, Ontario.
-
Slot Machine Gamblers Get Hooked in Trance-Like State
Findings from a recent study show gamblers who get immersed in playing slot machines are more at risk to develop gambling problems as a result.
-
Novo Nordisk to Open Oxford Diabetes Research Center
The pharmaceutical company Novo Nordisk will build a research center to study type 2 diabetes on the campus of University of Oxford in the U.K.
-
Cell Biotech Gains Organoid Technology
A Canadian biotechnology enterprise is licensing a technology that generates organoids, three-dimensional clusters of cells from stem cells that can form into gastrointestinal organs.
-
Peptide-Infused Gel Shown to Heal Chronic Wounds
A tissue engineering group developed a gel material infused with a synthetic peptide that in lab cultures and animals healed chronic diabetic wounds faster than a current commercial treatment.
-
Stem Cell Therapy Company Formed, Staked to $225M
A pharmaceutical company and health care venture investor are forming BlueRock Therapeutics, a biotechnology enterprise to design regenerative medicine treatments with stem cells.